Patients with chronic obstructive pulmonary disease (COPD) are frequently treated with
inhaled corticosteroids (ICS). However, the impact of ICS use on fracture risk remains …

Background: Inhaled corticosteroids are used increasingly to treat people with COPD, but
the extent to which these drugs increase the risk of fracture is unclear. Aim: To quantify the …

Objective To examine nonvertebral fracture risk in relation to inhaled corticosteroid (ICS)
exposure among adults with respiratory disease. Design and patients Nested case-control …

Background It is uncertain whether long-term use of inhaled corticosteroids (ICSs), widely
used to treat COPD, increases the risk of fracture, particularly in women, in view of the …

Background The effect of inhaled corticosteroids (ICS) on fracture risk in patients with
chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study was …

Osteoporosis is a major complication of long-term corticosteroid administration, but the
magnitude of the effect in patients with chronic obstructive pulmonary disease (COPD) is not …

Patients with chronic obstructive pulmonary disease (COPD) demonstrate a greater
osteoporosis prevalence than the general population. This osteoporosis risk may be …

Background Previous studies have found an association between the use of inhaled
corticosteroids and fracture, but the extent to which this association is due to inhaled …

The effect of inhaled corticosteroids (ICS) on the risk of osteoporosis and fracture in patients
with chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study …

Studies of the risk of fracture associated with inhaled corticosteroids are inconclusive and
are limited to short-term effects. We assessed whether long-term use increases this risk. We …